BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2808627
Number of visits today
782
Number of downloads
2060627
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Lampis A, Ratti M, Ghidini M, Mirchev MB, Okuducu AF, Valeri N, Hahne JC. Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review). Int J Mol Med 2021;47:97. [PMID: 33846775 DOI: 10.3892/ijmm.2021.4930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Cai L, Wu M, Li G, Zhu Y, Lin X, Yan X, Mo P, Luo H, Fu Z. Real-world experience with anti–programmed cell death protein 1 immunotherapy in patients with esophageal cancer: A retrospective single-center study. Front Oncol 2022;12:880053. [DOI: 10.3389/fonc.2022.880053] [Reference Citation Analysis]
2 Darling HS. Advances in immunotherapy for metastatic esophageal cancer. IJMIO 2022;0:1-8. [DOI: 10.25259/ijmio_14_2022] [Reference Citation Analysis]
3 Leone V, Peschke K, Reichert M. A Pancreatic Cancer Patient-Derived Xenograft Model for Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymphocytes. Gastro Hep Advances 2022;1:1122-1123. [DOI: 10.1016/j.gastha.2022.08.008] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345